Organon & Co. Files 8-K on Financial Results
Ticker: OGN · Form: 8-K · Filed: Apr 30, 2026 · CIK: 0001821825
| Field | Detail |
|---|---|
| Company | Organon &Amp; Co. (OGN) |
| Form Type | 8-K |
| Filed Date | Apr 30, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, 8-k, reporting
TL;DR
Organon dropped its Q1 2026 earnings report, check the 8-K for deets.
AI Summary
Organon & Co. filed an 8-K on April 30, 2026, reporting its results of operations and financial condition. The filing includes financial statements and exhibits, with specific XBRL data available for detailed analysis.
Why It Matters
This filing provides crucial updates on Organon & Co.'s financial performance, which can impact investor decisions and market perception.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing with no immediate indication of significant new risks.
Key Players & Entities
- Organon & Co. (company) — Filer of the 8-K report
- 0001821825 (company) — CIK number for Organon & Co.
- 2026-04-30 (date) — Period of report and filing date
FAQ
What specific financial information is being reported in this 8-K?
The 8-K reports on Organon & Co.'s 'Results of Operations and Financial Condition' as per Item 2.02.
When was this 8-K filing accepted by the SEC?
The filing was accepted on April 30, 2026, at 07:48:45.
What are the main document types included in this filing?
The filing includes the Form 8-K itself, Exhibit 99.1 (likely containing financial statements or press releases), and XBRL data.
Where is Organon & Co. located based on the filing?
Organon & Co.'s mailing and business address is listed as 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302.
What is the SIC code associated with Organon & Co.?
The SIC code for Organon & Co. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 30, 2026 regarding Organon & Co. (OGN).